Navigation Links
Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
Date:11/4/2008

LAKE FOREST, Ill., Nov. 4 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that Christopher B. Begley, chairman and chief executive officer, and Thomas E. Werner, senior vice president, Finance, and chief financial officer, will make a formal presentation at the 2008 Annual Credit Suisse Health Care Conference on Wednesday, Nov. 12, 2008, in Phoenix.

The presentation is scheduled to begin at noon Mountain time on Wednesday, Nov. 12, 2008. It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's Web site at http://www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the audiocast. The slides accompanying the presentation will be available on the Hospira Web site. A replay of the webcast will be available on the Hospira Web site approximately 24 hours after the live presentation.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection
2. Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
3. Hospira Reports Second-Quarter 2008 Results
4. Hospira Hosts Conference Call for Second-Quarter 2008 Earnings
5. Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders
6. Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
7. Hospira Acquires Sculptor
8. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
9. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
10. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
11. Hospira Launches Generic Irinotecan Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... 2017 , ... This morning, more than 275 medical doctors, ... for an independent Vaccine Safety Commission. Five of the signers of the letter, ... a press conference at 9:00 AM Friday, March 31 at the National ...
(Date:3/29/2017)... ... March 29, 2017 , ... Full Contact K9, an Atlanta-based dog services provider, ... that assists dog owners in creating legally-enforceable pet trusts for their canine companions. ... next step to protect their new companion. Says Evan Dunbar, CEO of Full Contact ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sports Brand EXOUS Bodygear ... which retails normally at $29.97; for the remaining days of March, the price will ... reduced to a special price of just $10 (regular retail price $19.97). , The ...
(Date:3/29/2017)... ... March 29, 2017 , ... Patients interested in receiving quick ... Dr. Jamie Cameron, with or without a referral. The FASTBRACES system is valued ... on each patient’s case, treatment with the FASTBRACES system could be completed in ...
(Date:3/29/2017)... ... ... Curio Wellness , a premium medical cannabis brand and trusted healthcare partner ... with prominent executives from both inside and outside the cannabis industry. , Joining ... , who has more than twenty years of business leadership and investment experience in ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... , March 30, 2017  Purcell Julie & Lefkowitz LLP, ... is investigating a potential breach of fiduciary duty claim involving ... SGYP ). If you are a ... information regarding this investigation, free of charge, please visit us ... ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... ... chromatograph market to grow at a CAGR of 5.20% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:3/29/2017)... -- Research and Markets has announced the addition of the ... Forecast" report to their offering. ... Proton Therapy Market in Italy will ... There are currently three proton therapy centers in Italy ... Italy , the first patients were treated with proton ...
Breaking Medicine Technology: